- Home
- KTTA vs ZIMV Comparison
KTTA vs ZIMV Comparison
Compare KTTA & ZIMV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ZIMV
- Stock Information
- Founded
- KTTA 2020
- ZIMV 2021
- Country
- KTTA United States
- ZIMV United States
- Employees
- KTTA N/A
- ZIMV N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KTTA Health Care
- ZIMV Health Care
- Exchange
- KTTA Nasdaq
- ZIMV Nasdaq
- Market Cap
- KTTA 5.5M
- ZIMV 262.9M
- IPO Year
- KTTA 2021
- ZIMV N/A
- Fundamental
- Price
- KTTA $0.69
- ZIMV $8.87
- Analyst Decision
- KTTA
- ZIMV Hold
- Analyst Count
- KTTA 0
- ZIMV 2
- Target Price
- KTTA N/A
- ZIMV $10.00
- AVG Volume (30 Days)
- KTTA 136.4K
- ZIMV 138.2K
- Earning Date
- KTTA 08-12-2025
- ZIMV 07-31-2025
- Dividend Yield
- KTTA N/A
- ZIMV N/A
- EPS Growth
- KTTA N/A
- ZIMV N/A
- EPS
- KTTA N/A
- ZIMV N/A
- Revenue
- KTTA N/A
- ZIMV $443,551,000.00
- Revenue This Year
- KTTA N/A
- ZIMV $1.96
- Revenue Next Year
- KTTA N/A
- ZIMV $1.95
- P/E Ratio
- KTTA N/A
- ZIMV N/A
- Revenue Growth
- KTTA N/A
- ZIMV N/A
- 52 Week Low
- KTTA $0.67
- ZIMV $8.15
- 52 Week High
- KTTA $7.50
- ZIMV $22.40
- Technical
- Relative Strength Index (RSI)
- KTTA 32.71
- ZIMV 45.41
- Support Level
- KTTA $0.67
- ZIMV $9.31
- Resistance Level
- KTTA $0.77
- ZIMV $10.26
- Average True Range (ATR)
- KTTA 0.03
- ZIMV 0.44
- MACD
- KTTA 0.01
- ZIMV -0.04
- Stochastic Oscillator
- KTTA 22.68
- ZIMV 26.63
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.